Lack of interaction between caffeine, tolbutamide, and dextromethorphan.

被引：0
|
作者：
Gorski, JC [1 ]
Bruce, M [1 ]
Haehner-Daniels, BD [1 ]
Craven, R [1 ]
Hall, SD [1 ]
机构：
[1] Indiana Univ, Sch Med, Div Clin Pharmacol, Indianapolis, IN USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2001年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P37 / P37
页数：1
相关论文
共 50 条
  • [1] Lack of interaction between tolcapone and tolbutamide in healthy volunteers
    Jorga, KM
    Fotteler, B
    Gasser, R
    Banken, L
    Birnboeck, H
    JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (05): : 544 - 551
  • [2] Lack of pharmacokinetic interaction between morphine and dextromethorphan in healthy volunteers.
    Caruso, FS
    Johnson, DA
    Noonan, PK
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 122 - 122
  • [3] LACK OF INTERACTION BETWEEN LOMEFLOXACIN AND CAFFEINE IN NORMAL VOLUNTEERS
    HEALY, DP
    SCHOENLE, JR
    STOTKA, J
    POLK, RE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (04) : 660 - 664
  • [4] Lack of dextromethorphan interaction with P-glycoprotein.
    Kanaan, M
    Daali, Y
    Dayer, P
    Desmeules, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P10 - P10
  • [5] Lack of pharmacokinetic interaction between dextromethorphan, coumarin and mephenytoin in man after simultaneous administration
    Endres, HGE
    Henschel, L
    Merkel, U
    Hippius, M
    Hoffmann, A
    PHARMAZIE, 1996, 51 (01): : 46 - 51
  • [6] Post-methotrexate (MTX) CNS toxicity: Symptom reduction with dextromethorphan.
    Bettachi, CJ
    Kamen, BA
    Cush, JJ
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S236 - S236
  • [7] DRUG INTERACTION BETWEEN IBUPROFEN AND TOLBUTAMIDE
    ANDERSEN, LA
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1978, 7 (03) : 149 - 149
  • [8] Pharmacokinetic drug interaction potential of risperidone as assessed by the dextromethorphan, the caffeine and the mephenytoin test
    Eap, CB
    Bondolfi, G
    Zullino, D
    Bryois, C
    Fuciec, M
    Savary, L
    Jonzier-Perey, M
    Baumann, P
    EUROPEAN PSYCHIATRY, 2000, 15 : 394S - 395S
  • [9] LACK OF RELATIONSHIP BETWEEN TOLBUTAMIDE METABOLISM AND DEBRISOQUINE OXIDATION PHENOTYPE
    PEART, GF
    BOUTAGY, J
    SHENFIELD, GM
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 33 (04) : 397 - 402
  • [10] LACK OF RELATIONSHIP BETWEEN DEBRISOQUINE OXIDATION PHENOTYPE AND THE KINETICS OF TOLBUTAMIDE
    SHENFIELD, GM
    BOUTAGY, J
    PEART, GFD
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 116 - 116
12345